These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


306 related items for PubMed ID: 4715833

  • 1. [Present-day possibilities of relieving post-neuroleptic extrapyramidal symptoms].
    Wasik A.
    Psychiatr Pol; 1973; 7(1):51-6. PubMed ID: 4715833
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Action of amantadine in extrapyramidal syndromes caused by neuroleptics].
    Fanali A, Nardini M, Sorgona F.
    Sist Nerv; 1970; 22(5):273-85. PubMed ID: 5514245
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Tranquilizing agents: extrapyramidal and antiparkinsonism activities].
    Bordeleau JM, Tétreault L, Elie R.
    Vie Med Can Fr; 1972 Feb; 1(2):118-26. PubMed ID: 4637390
    [No Abstract] [Full Text] [Related]

  • 9. [Evaluation in clinical trials of some drug associations. (L-dopa, neuroleptics and lithium carbonate)].
    Longo V, Kemali D, Pacini A, Bertolino A, Lamura G.
    Boll Soc Ital Biol Sper; 1971 Aug 15; 47(15):470-2. PubMed ID: 5158530
    [No Abstract] [Full Text] [Related]

  • 10. Dexetimide (R 16470) in the control of neuroleptic-induced extrapyramidal side-effects. Its prophylactic value and duration of action.
    Huygens H, Vereecken JL, Tanghe A.
    Psychiatr Neurol Neurochir; 1973 Aug 15; 76(4):251-9. PubMed ID: 4581374
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Syndrome involving the extrapyramidal motor systems and their drug treatment].
    Soyka D.
    Fortschr Med; 1974 Aug 08; 92(22):906-9. PubMed ID: 4153689
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Neuroleptics, thymoleptics and tranquilizers in neurological therapy].
    Hertrich O.
    Bibl Psychiatr Neurol; 1969 Aug 08; 139():88-113. PubMed ID: 4400242
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Antiparkinson medication in the treatment of extrapyramidal side effects: single of multiple daily doses?
    Neu C, Dimascio A, Demirgian E.
    Curr Ther Res Clin Exp; 1972 May 08; 14(5):246-51. PubMed ID: 4623975
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Clinical trial of tropatepine chlorhydrate as a corrector of syndromes due to neuroleptics].
    Delaunay J, Guibert S.
    Ann Med Psychol (Paris); 1976 Jan 08; 1(1):144-7. PubMed ID: 970819
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 16.